There is a significant need for improved treatment options in Chronic Pulmonary Diseases like bronchiectasis and COPD, as well as acute pulmonary conditions.
Synspire Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to significantly improving the lives of people with Pulmonary Disease.
We are committed to developing a disease-focused platform to provide novel therapies that overcome the limitations of existing treatments, improve outcomes, reduce patient burden, and can easily become part of patient lives.
